Drug-drug interaction potential of the HBV and HDV entry inhibitor myrcludex B assessed in vitro

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Blank, Antje (VerfasserIn) , Meier, Katrin (VerfasserIn) , Urban, Stephan (VerfasserIn) , Haefeli, Walter E. (VerfasserIn) , Weiß, Johanna (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2018
In: Antiviral therapy
Year: 2017, Jahrgang: 23, Heft: 3, Pages: 267-275
ISSN:2040-2058
DOI:10.3851/IMP3206
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.3851/IMP3206
Verlag, Volltext: https://www.intmedpress.com/journals/avt/abstract.cfm?id=3206&pid=48
Volltext
Verfasserangaben:Antje Blank, Katrin Meier, Stephan Urban, Walter Emil Haefeli, Johanna Weiss

MARC

LEADER 00000caa a22000002c 4500
001 158039857X
003 DE-627
005 20230427065657.0
007 cr uuu---uuuuu
008 180827r20182017xx |||||o 00| ||eng c
024 7 |a 10.3851/IMP3206  |2 doi 
035 |a (DE-627)158039857X 
035 |a (DE-576)51039857X 
035 |a (DE-599)BSZ51039857X 
035 |a (OCoLC)1341017626 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Blank, Antje  |e VerfasserIn  |0 (DE-588)1061215962  |0 (DE-627)805162364  |0 (DE-576)174275722  |4 aut 
245 1 0 |a Drug-drug interaction potential of the HBV and HDV entry inhibitor myrcludex B assessed in vitro  |c Antje Blank, Katrin Meier, Stephan Urban, Walter Emil Haefeli, Johanna Weiss 
246 3 3 |a Drug-drug interaction potential of the hepatitis B and hepatitis D virus entry inhibitor myrcludex B assessed in vitro 
264 1 |c 2018 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 27.08.2018 
500 |a Published online 14 November 2017 
534 |c 2017 
700 1 |a Meier, Katrin  |e VerfasserIn  |0 (DE-588)1165518481  |0 (DE-627)1029455635  |0 (DE-576)510400493  |4 aut 
700 1 |a Urban, Stephan  |e VerfasserIn  |0 (DE-588)1060263599  |0 (DE-627)79935399X  |0 (DE-576)174162049  |4 aut 
700 1 |a Haefeli, Walter E.  |d 1958-  |e VerfasserIn  |0 (DE-588)124572359  |0 (DE-627)656806141  |0 (DE-576)340514221  |4 aut 
700 1 |a Weiß, Johanna  |e VerfasserIn  |0 (DE-588)1050230906  |0 (DE-627)783666322  |0 (DE-576)404441114  |4 aut 
773 0 8 |i Enthalten in  |t Antiviral therapy  |d London : Sage, 1998  |g 23(2018), 3, Seite 267-275  |h Online-Ressource  |w (DE-627)369083024  |w (DE-600)2118396-X  |w (DE-576)347267513  |x 2040-2058  |7 nnas  |a Drug-drug interaction potential of the HBV and HDV entry inhibitor myrcludex B assessed in vitro 
773 1 8 |g volume:23  |g year:2018  |g number:3  |g pages:267-275  |g extent:9  |a Drug-drug interaction potential of the HBV and HDV entry inhibitor myrcludex B assessed in vitro 
856 4 0 |u http://dx.doi.org/10.3851/IMP3206  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.intmedpress.com/journals/avt/abstract.cfm?id=3206&pid=48  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180827 
993 |a Article 
994 |a 2018 
998 |g 1050230906  |a Weiß, Johanna  |m 1050230906:Weiß, Johanna  |d 910000  |d 910100  |e 910000PW1050230906  |e 910100PW1050230906  |k 0/910000/  |k 1/910000/910100/  |p 5  |y j 
998 |g 124572359  |a Haefeli, Walter E.  |m 124572359:Haefeli, Walter E.  |d 910000  |d 910100  |e 910000PH124572359  |e 910100PH124572359  |k 0/910000/  |k 1/910000/910100/  |p 4 
998 |g 1060263599  |a Urban, Stephan  |m 1060263599:Urban, Stephan  |d 910000  |d 911700  |d 700000  |d 718000  |e 910000PU1060263599  |e 911700PU1060263599  |e 700000PU1060263599  |e 718000PU1060263599  |k 0/910000/  |k 1/910000/911700/  |k 0/700000/  |k 1/700000/718000/  |p 3 
998 |g 1165518481  |a Meier, Katrin  |m 1165518481:Meier, Katrin  |d 910000  |d 910100  |e 910000PM1165518481  |e 910100PM1165518481  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1061215962  |a Blank, Antje  |m 1061215962:Blank, Antje  |d 910000  |d 910100  |e 910000PB1061215962  |e 910100PB1061215962  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN158039857X  |e 3023860041 
BIB |a Y 
SER |a journal 
JSO |a {"titleAlt":[{"title":"Drug-drug interaction potential of the hepatitis B and hepatitis D virus entry inhibitor myrcludex B assessed in vitro"}],"note":["Gesehen am 27.08.2018","Published online 14 November 2017"],"relHost":[{"pubHistory":["Nachgewiesen 3.1998 -"],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 16.03.2022"],"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"title_sort":"Antiviral therapy","title":"Antiviral therapy","subtitle":"an official publication of the International Society for Antiviral Research"}],"disp":"Drug-drug interaction potential of the HBV and HDV entry inhibitor myrcludex B assessed in vitroAntiviral therapy","recId":"369083024","part":{"pages":"267-275","volume":"23","extent":"9","text":"23(2018), 3, Seite 267-275","year":"2018","issue":"3"},"origin":[{"publisherPlace":"London ; London","dateIssuedDisp":"1998-","dateIssuedKey":"1998","publisher":"Sage ; International Medical Press"}],"id":{"eki":["369083024"],"issn":["2040-2058"],"zdb":["2118396-X"]}}],"person":[{"family":"Blank","given":"Antje","role":"aut","display":"Blank, Antje"},{"display":"Meier, Katrin","family":"Meier","given":"Katrin","role":"aut"},{"family":"Urban","role":"aut","given":"Stephan","display":"Urban, Stephan"},{"family":"Haefeli","given":"Walter E.","role":"aut","display":"Haefeli, Walter E."},{"display":"Weiß, Johanna","role":"aut","given":"Johanna","family":"Weiß"}],"title":[{"title_sort":"Drug-drug interaction potential of the HBV and HDV entry inhibitor myrcludex B assessed in vitro","title":"Drug-drug interaction potential of the HBV and HDV entry inhibitor myrcludex B assessed in vitro"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"physDesc":[{"extent":"9 S."}],"id":{"doi":["10.3851/IMP3206"],"eki":["158039857X"]},"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"2018"}],"name":{"displayForm":["Antje Blank, Katrin Meier, Stephan Urban, Walter Emil Haefeli, Johanna Weiss"]},"recId":"158039857X"} 
SRT |a BLANKANTJEDRUGDRUGIN2018